Volume 14 Supplement 2
Abstracts from the International Symposium HIV and Emerging Infectious Diseases 2014
Meeting abstracts
Publication of this supplement has been funded by the Overcome Agency.
International Symposium HIV and Emerging Infectious Diseases 2014. Go to conference site.
Marseille, France21-23 May 2014
Page 2 of 3
-
Citation: BMC Infectious Diseases 2014 14(Suppl 2):P33
-
Vulnerability to HIV of Internally Displaced Persons in the Republic of Serbia
Citation: BMC Infectious Diseases 2014 14(Suppl 2):P34 -
Reducing mother to child HIV transmission: a successful experience
Citation: BMC Infectious Diseases 2014 14(Suppl 2):P35 -
Personalizing humanized mice with cells obtained from an HIV post treatment controller
Citation: BMC Infectious Diseases 2014 14(Suppl 2):P36 -
Hearing sensitivity in perinatally HIV-infected children
Citation: BMC Infectious Diseases 2014 14(Suppl 2):P37 -
High mortality among people living with HIV and AIDS accessing care at hospitals in Ghana. Do they report too late?
Citation: BMC Infectious Diseases 2014 14(Suppl 2):P38 -
Opportunistic digestive parasitic infections in adults infected with HIV: epidemiological expression
Citation: BMC Infectious Diseases 2014 14(Suppl 2):P39 -
Microbial infections in HIV/AIDS women with abnormal vaginal discharge in Lagos, Nigeria
Citation: BMC Infectious Diseases 2014 14(Suppl 2):P40 -
TB-IRIS among HIV patients in an urban private medical clinic, Malawi
Citation: BMC Infectious Diseases 2014 14(Suppl 2):P41 -
Aetiology of fever among under fives in Lagos, Nigeria
Citation: BMC Infectious Diseases 2014 14(Suppl 2):P42 -
Factors affecting quality of life of people living with HIV/AIDS attending a community care center in Chennai, India
Citation: BMC Infectious Diseases 2014 14(Suppl 2):P43 -
Are health care workers (HCWs) of long term care facilities (LTC) ready to take care of HIV older patients?
Citation: BMC Infectious Diseases 2014 14(Suppl 2):P44 -
The cases with opportunistic infections among HIV patients in Indonesia 2011
Citation: BMC Infectious Diseases 2014 14(Suppl 2):P45 -
Socio-epidemiological and therapeutic profile of patients infected by HIV in 2011 at Tunis (Tunisia)
Citation: BMC Infectious Diseases 2014 14(Suppl 2):P46 -
Surgical treatment of perforative tubercular intestines ulcers at patients with HIV infection
Citation: BMC Infectious Diseases 2014 14(Suppl 2):P47 -
Is anemia still a problem in cART era: a single center study?
Citation: BMC Infectious Diseases 2014 14(Suppl 2):P48 -
Cutaneous drug-reactions to nevirapine: study of risk factors in 268 HIV-infected patients
Citation: BMC Infectious Diseases 2014 14(Suppl 2):P49 -
Spectrums of opportunistic infections in HIV-Infected patients in referral hospital of Setif (Algeria)
Citation: BMC Infectious Diseases 2014 14(Suppl 2):P50 -
Cutaneous anaplastic large cell lymphoma in HIV exceptional case in Algeria
Citation: BMC Infectious Diseases 2014 14(Suppl 2):P51 -
Intestinal cryptosporidiosis in HIV-infected patients in the department of infectious diseases
Citation: BMC Infectious Diseases 2014 14(Suppl 2):P52 -
Epidemiological aspects of new HIV/AIDS diagnoses in south-east Romania
Citation: BMC Infectious Diseases 2014 14(Suppl 2):P53 -
Opportunistic infections in HIV positive patients in Bahrain in 4 years study 2009-2013
Citation: BMC Infectious Diseases 2014 14(Suppl 2):P54 -
Support for current patients infected addicts
Citation: BMC Infectious Diseases 2014 14(Suppl 2):P55 -
Morphological spectrum of lymphadenopathy in AIDS patients
Citation: BMC Infectious Diseases 2014 14(Suppl 2):P56 -
Serial passage of HIV-2F: a pigtail macaque model for HIV emergence
Citation: BMC Infectious Diseases 2014 14(Suppl 2):P57 -
Ultra-deep sequencing of HIV-1 near full-length and partial proviral genomes from recently infected blood donors at four blood centers in Brazil
Citation: BMC Infectious Diseases 2014 14(Suppl 2):P58 -
PMTCT of HIV-1 in Burkina Faso: evaluation of residual vertical transmission by PCR, molecular characterization of subtypes and determination of antiretroviral drugs resistance
Citation: BMC Infectious Diseases 2014 14(Suppl 2):P59 -
HIV-1 CRF08_BC mutants resistant to reverse transcriptase inhibitors
Citation: BMC Infectious Diseases 2014 14(Suppl 2):P60 -
Ultra-deep sequencing of HIV-1 near full-length and partial proviral genomes among chronically infected blood donors at four blood centers in Brazil
Citation: BMC Infectious Diseases 2014 14(Suppl 2):P61 -
Complete genome sequence of new unique recombinant HIV type 1 isolated from a child born to an HIV-infected mother
Citation: BMC Infectious Diseases 2014 14(Suppl 2):P62 -
HIV-1 Tat promotes premature brain aging
Citation: BMC Infectious Diseases 2014 14(Suppl 2):P63 -
The potential role of HIV-specific CD38-/HLA-DR+ CD8+ T cells in viral suppressive activity and cytotoxicity in HIV controllers
Citation: BMC Infectious Diseases 2014 14(Suppl 2):P64 -
Increase in frequencies of circulating Th-17 cells in HIV-1 infected patients with poor CD4+ T-cell reconstitution on effective HAART
Citation: BMC Infectious Diseases 2014 14(Suppl 2):P65 -
An impact of HIV disease severity on in vitro CD4+ T cell expansion using anti-CD3/28 coated magnetic beads for being used as an alternative treatment in HIV infected patients
Citation: BMC Infectious Diseases 2014 14(Suppl 2):P66 -
Resistance to HIV-1 infection among HIV-exposed seronegative partners in HIV-discordant couples is associated with higher frequency of CD8+ T cells expressing CD107a and b molecules
Citation: BMC Infectious Diseases 2014 14(Suppl 2):P67 -
Differential glycosylation of envelope gp120 affects reactivity with HIV-1 specific antibodies
Citation: BMC Infectious Diseases 2014 14(Suppl 2):P68 -
CKR-L3, a deletion version CCR6-isoform shows coreceptor-activity for limited human and simian immunodeficiency viruses
Citation: BMC Infectious Diseases 2014 14(Suppl 2):P69 -
Assessment of the ability DS-EIA-HIV-AB-TERM assay correctly identify long-standing and recent HIV infection
Citation: BMC Infectious Diseases 2014 14(Suppl 2):P70 -
Evaluation of the Bio-Rad Geenius HIV-1/2 test as a confirmatory assay
Citation: BMC Infectious Diseases 2014 14(Suppl 2):P71 -
48 week bone marker changes with Dolutegravir (DTG) plus Abacavir/Lamivudine (ABC/3TC) vs. Tenofovir/Emtricitabine/Efavirenz (EFV/TDF/FTC): the SINGLE trial
Citation: BMC Infectious Diseases 2014 14(Suppl 2):P72 -
Optimizing HIV treatment through point-of-care CD4 testing – ACHAP Botswana community-based pilot
Citation: BMC Infectious Diseases 2014 14(Suppl 2):P73 -
Optimized production of a safe and efficient gene therapeutic vaccine versus HIV via a linear covalently closed DNA minivector
Citation: BMC Infectious Diseases 2014 14(Suppl 2):P74 -
Chitosan nanoparticles for the intracellular delivery of triphosphate nucleotide analogues
Citation: BMC Infectious Diseases 2014 14(Suppl 2):P75 -
Viral suppression among young adults in a US outpatient clinic
Citation: BMC Infectious Diseases 2014 14(Suppl 2):P76 -
Novel MDR-reversing inhibitors of MRP subtypes related to antiretroviral drug resistance and CD4 cell counts
Citation: BMC Infectious Diseases 2014 14(Suppl 2):P77 -
Who are they? Identifying risk factors of loss to follow up among HIV+ patients on care and treatment in Dar es Salaam
Citation: BMC Infectious Diseases 2014 14(Suppl 2):P78 -
Dual anti-HSV and anti-HIV activity of the lantibiotic Labyrinthopeptin A1
Citation: BMC Infectious Diseases 2014 14(Suppl 2):P79 -
Too bad! Fixed dose combination antiretroviral drugs
Citation: BMC Infectious Diseases 2014 14(Suppl 2):P80 -
Lentiviral-based anti-HIV therapeutic vaccine: design, preclinical studies and phaseI/II clinical trial preliminary results
Citation: BMC Infectious Diseases 2014 14(Suppl 2):P81 -
Outcomes of HIV pregnant women on Option B+ treatment in an urban Malawian private medical clinic, between July 2011 and November 2013
Citation: BMC Infectious Diseases 2014 14(Suppl 2):P82
Annual Journal Metrics
-
2022 Citation Impact
3.7 - 2-year Impact Factor
3.6 - 5-year Impact Factor
1.283 - SNIP (Source Normalized Impact per Paper)
1.055 - SJR (SCImago Journal Rank)2022 Speed
21 days submission to first editorial decision for all manuscripts (Median)
154 days submission to accept (Median)2022 Usage
10,831,430 downloads
74,440 Altmetric mentions
Peer-review Terminology
-
The following summary describes the peer review process for this journal:
Identity transparency: Single anonymized
Reviewer interacts with: Editor
Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication